CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a non-invasive method for early detection of lung cancer using a microfluidic chip that combines Micro-RNA bioassays with Surface Enhanced Raman Scattering technology. The system targets specific miRNA biomarkers, allowing for rapid and sensitive identification of cancer cells in sputum sam…
Lung cancer is one of the leading causes of cancer mortality in the world accounting for an estimated 1.8 million deaths, 18.4% of the total in 2018.
Approximately 85% of lung cancers are classified as non-small cell lung cancer (NSCLC), a less aggressive form of tumor than small cell lung cancer (the remaining 15% of all lung cancers).
The gold standard diagnostic methods for lung cancer patients include X-ray, low-dose CT and sputum cytology which are not efficient for early stage diagnosis o…
UNIVERSIDAD DE VIGO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
